{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T12:45:43Z","timestamp":1781268343622,"version":"3.54.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T00:00:00Z","timestamp":1427414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0120511","type":"journal-article","created":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T02:25:02Z","timestamp":1427595902000},"page":"e0120511","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Correlation between Activation of PI3K\/AKT\/mTOR Pathway and Prognosis of Breast Cancer in Chinese Women"],"prefix":"10.1371","volume":"10","author":[{"given":"Ling","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Rong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Fen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Juan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"P Liu","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0165-6147(03)00163-9","article-title":"Phosphoinositide 3-kinase signalling\u2014which way to target?","volume":"24","author":"MP Wymann","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00401-006-0186-1","article-title":"PIK3CA alterations in primary (de novo) and secondary glioblastomas","volume":"113","author":"D Kita","year":"2007","journal-title":"Acta Neuropathol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"R609","DOI":"10.1186\/bcr1262","article-title":"Somatic mutation and gain of copy number of PIK3CA in human breast cancer","volume":"7","author":"G Wu","year":"2005","journal-title":"Breast Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.lungcan.2007.06.020","article-title":"PIK3CA gene amplification in Japanese non-small cell lung cancer","volume":"58","author":"O Kawano","year":"2007","journal-title":"Lung Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/annonc\/mdp347","article-title":"Status of PI3K inhibition and biomarker development in cancer therapeutics","volume":"21","author":"B Markman","year":"2010","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1755-148X.2010.00796.x","article-title":"mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics","volume":"24","author":"H Populo","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"E1139","DOI":"10.1210\/jc.2011-2748","article-title":"mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma","volume":"97","author":"A Faustino","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1158\/0008-5472.CAN-04-2933","article-title":"Mutation of the PIK3CA gene in ovarian and breast cancer","volume":"64","author":"IG Campbell","year":"2004","journal-title":"Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bjc.6602970","article-title":"Mutation of the PIK3CA oncogene in human cancers","volume":"94","author":"B Karakas","year":"2006","journal-title":"Br J Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","article-title":"High frequency of mutations of the PIK3CA gene in human cancers","volume":"304","author":"Y Samuels","year":"2004","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nrd1902","article-title":"Exploiting the PI3K\/AKT pathway for cancer drug discovery","volume":"4","author":"BT Hennessy","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1158\/0008-5472.CAN-07-6854","article-title":"An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer","volume":"68","author":"K Stemke-Hale","year":"2008","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature05933","article-title":"A transforming mutation in the pleckstrin homology domain of AKT1 in cancer","volume":"448","author":"JD Carpten","year":"2007","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e22769","DOI":"10.1371\/journal.pone.0022769","article-title":"PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers","volume":"6","author":"F Janku","year":"2011","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"9221","DOI":"10.1158\/0008-5472.CAN-08-1740","article-title":"Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR\/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235","volume":"68","author":"PJ Eichhorn","year":"2008","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/PAI.0b013e3181d50bd5","article-title":"Protocol for PTEN expression by immunohistochemistry in formalin-fixed paraffin-embedded human breast carcinoma","volume":"18","author":"RA Sakr","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1634\/theoncologist.2010-0402","article-title":"Targeting the phosphatidylinositol 3-kinase signaling pathway in breast cancer","volume":"16","author":"LF Hernandez-Aya","year":"2011","journal-title":"Oncologist"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/1078-0432.CCR-06-0267","article-title":"Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women","volume":"13","author":"N Maruyama","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1158\/1078-0432.CCR-06-1609","article-title":"PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer","volume":"13","author":"G Perez-Tenorio","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10549-009-0575-y","article-title":"Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer","volume":"119","author":"MJ Ellis","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10549-011-1572-5","article-title":"Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer","volume":"128","author":"E Razis","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/annonc\/mdr546","article-title":"PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab","volume":"23","author":"JD Jensen","year":"2012","journal-title":"Ann Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1113216","article-title":"Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer","volume":"366","author":"J Baselga","year":"2012","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1158\/0008-5472-CAN-04-3913","article-title":"PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma","volume":"65","author":"LH Saal","year":"2005","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/modpathol.3800296","article-title":"Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen","volume":"18","author":"N Shoman","year":"2005","journal-title":"Mod Pathol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/modpathol.3880371","article-title":"Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer","volume":"14","author":"PL Depowski","year":"2001","journal-title":"Mod Pathol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00129039-200409000-00004","article-title":"Reduced PTEN expression is associated with poor outcome and angiogenesis in invasive ductal carcinoma of the breast","volume":"12","author":"JS Lee","year":"2004","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2559.2012.04255.x","article-title":"Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer","volume":"61","author":"J Iqbal","year":"2012","journal-title":"Histopathology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10549-005-9048-0","article-title":"PIK3CA mutations in breast cancer are associated with poor outcome","volume":"96","author":"SY Li","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1073\/pnas.0907011107","article-title":"PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer","volume":"107","author":"S Loi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/annonc\/mdn739","article-title":"Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer","volume":"20","author":"AU Buzdar","year":"2009","journal-title":"Ann Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev-med-070909-182917","article-title":"Mechanisms of endocrine resistance in breast cancer","volume":"62","author":"CK Osborne","year":"2011","journal-title":"Annu Rev Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1074\/jbc.M807532200","article-title":"S6 kinase 1 regulates estrogen receptor alpha in control of breast cancer cell proliferation","volume":"284","author":"RL Yamnik","year":"2009","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1158\/0008-5472.CAN-08-4450","article-title":"PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer","volume":"69","author":"RJ Crowder","year":"2009","journal-title":"Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1172\/JCI41680","article-title":"Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer","volume":"120","author":"TW Miller","year":"2010","journal-title":"J Clin Invest"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1158\/1078-0432.CCR-04-2402","article-title":"Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer","volume":"11","author":"A Boulay","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1109653","article-title":"Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer","volume":"366","author":"J Baselga","year":"2012","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0120511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:19:13Z","timestamp":1589037553000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0120511"}},"subtitle":[],"editor":[{"given":"Paula","family":"Soares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,27]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0120511","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,27]]}}}